Looking at real world evidence on PSA testing in prostate cancer

Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B

Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer

Do patients and doctors treatment aspirations align? KCCure survey – part A

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC

EAU 2024: Bladder cancer latest

Pembrolizumab a promising option for MIUC patients after radical surgery

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis